Research uncovers potential antibody to prevent central line infection
9/14/2013
A team of researchers at Cincinnati Children's Hospital Medical Center has developed an antibody that could prevent Candida infections that often afflict hospitalized patients who receive central lines...
NCI scientists identify targets for melanoma immunotherapy
9/13/2013
Using a highly sensitive technology called NanoString, researchers have identified seven targets that could potentially be used to develop new immunotherapies for patients with metastatic melanoma, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research...
FDA grants 510(k) clearance for NanoString in vitro breast cancer diagnostic assay
9/13/2013
NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Prosigna™ Breast Cancer Prognostic Gene Signature Assay...
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, has announced that the five-year follow-up of patients with high-risk malignancies from its Phase I/II clinical study confirms long-term safety and efficacy of ATIR(TM) over a broad dose range...
NCI scientists identify targets for melanoma immunotherapy
9/13/2013
Using a highly sensitive technology called NanoString, researchers have identified seven targets that could potentially be used to develop new immunotherapies for patients with metastatic melanoma, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research...
3 out of every 4 cases of bladder cancer display mutations in the same gene
9/13/2013
Researchers from the Spanish National Cancer Research Centre (CNIO) have discovered that more than 70% of bladder tumours display somatic mutations in the TERT gene (telomerase reverse transcriptase). The TERT gene is involved in the protection of DNA and in cellular ageing processes and cancer. These results make this gene the most mutated in these tumours. The study was led by Francisco X...
Experts take on challenge of breast density notification laws
9/13/2013
A team of California-based breast imagers and breast cancer risk specialists have developed a website to help navigate the new challenges posed by breast density notification laws, according to a special report published online in the journal Radiology...
What is endometrial cancer? What is uterine cancer?
9/13/2013
Endometrial cancer, also known as womb cancer or uterine cancer, is a type of cancer that begins in the uterus (womb), specifically in the layer of cells that form the lining of the uterus, called the endometrium. Endometrial cancer can also be called cancer of the womb or cancer of the uterus. Nearly all uterine cancers are endometrial cancer...
Redefining the criteria for ALK positive lung cancer
9/13/2013
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug...
Dental cavities linked to lower risk of head and neck cancer
9/13/2013
According to a surprising new study, people who have more dental cavities are at lower risk of being diagnosed with head and neck cancer, compared with patients who have few or no cavities. Dental cavities (or caries) are caused by tooth decay. This is when the bacteria present in the mouth make lactic acids that strip away minerals in the tooth by fermenting carbohydrates...